Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

FDA grants final approval to Cobrek’s generic Luxiq foam NDA for treatment of scalp psoriasis

Perrigo Company today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam.

28 Nov 2012

Gilead Sciences receives EC approval for Viread to treat HIV-1 infected children

Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for two new indications for once-daily Viread (tenofovir disoproxil fumarate).

28 Nov 2012

Neusoft Medical receives FDA 510k clearance for NeuViz 64 multi-slice CT scanner

Neusoft Medical Systems Co., Ltd., a wholly-owned subsidiary of Neusoft Corporation, announced today that the NeuViz 64 multi-slice CT scanner has received FDA 510k clearance.

27 Nov 2012

Philips Healthcare, UH to showcase latest medical technology at Cleveland Medical Mart

University Hospitals (UH) and Philips Healthcare are among a group of global leaders in healthcare to showcase the latest medical technology at the new Cleveland Medical Mart & Convention Center.

From Philips Healthcare 27 Nov 2012

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

Liver disease is a very broad family of diseases. There are two main categories of liver disease:

27 Nov 2012

Patheon announces cash tender offer for all outstanding 8.625% Senior Secured Notes

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that it is commencing a cash tender offer for any and all of its outstanding 8.625% Senior Secured Notes due 2017 (CUSIP Numbers 70319W AA6 (Rule 144A) and C7197E AA2 (Regulation S)), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated the date hereof, and in the related Letter of Transmittal.

27 Nov 2012

Food hardness affects bolus size, swallowing

The smaller the particles in a food bolus, the harder the food is likely to be, report researchers in the Archives of Oral Biology.

22 Nov 2012

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

The U.S. Food and Drug Administration announced today the approval of Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal cells, instead of fertilized chicken eggs. Flucelvax is approved to prevent seasonal influenza in people ages 18 years and older.

21 Nov 2012

Mazzetti, AGR to develop technologies that can capture anesthetic gases in hospitals

Engineering design and consulting firm Mazzetti Nash Lipsey Burch (Mazzetti) and Anesthetic Gas Reclamation, LLC (AGR) announced today that they are partnering to develop commercial applications for technology that recaptures anesthetic gases in hospitals.

21 Nov 2012

Computer-based simulation modeling to determine ED HIV screening costs

Introducing HIV screenings into the nation's emergency departments (EDs) leaves some doctors worrying about longer wait times, disrupted operations, and possible interference with necessary emergency services. Are their concerns unfounded? New research at the University of Cincinnati will use computer-based simulation modeling to determine how screening for HIV in the emergency department will affect how those departments operate.

21 Nov 2012

Patheon to launch $30 million transferable rights offering

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it will launch a U.S. $30 million transferable rights offering.

19 Nov 2012

KemPharm announces successful Type B meeting with FDA for KP201

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.

19 Nov 2012

Certain occupations do increase risk of breast cancer

Is there a link between the risk of breast cancer and the working environment? A study published in BioMed Central's open access journal Environmental Health provides further evidence on this previously neglected research topic, confirming that certain occupations do pose a higher risk of breast cancer than others, particularly those that expose the worker to potential carcinogens and endocrine disrupters.

19 Nov 2012

New nanoparticle halts relapsing remitting multiple sclerosis in mouse model

In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stopping its attack on myelin and halt a model of relapsing remitting multiple sclerosis (MS) in mice, according to new Northwestern Medicine research.

19 Nov 2012

NIH-funded scientists develop new treatment to combat autoimmune disorders in mouse model

In a mouse model of multiple sclerosis (MS), researchers funded by the National Institutes of Health have developed innovative technology to selectively inhibit the part of the immune system responsible for attacking myelin-the insulating material that encases nerve fibers and facilitates electrical communication between brain cells.

18 Nov 2012

United States Pharmacopeial Convention to host Fifth Bioassay Workshop in Rockville

As a growing number of biologic drugs are treatments of choice for an expanding list of autoimmune disorders, inflammatory diseases, and certain cancers, bioassays play a critical role in establishing the functional integrity and potency of these products.

17 Nov 2012

Thermo Fisher announces opening of new facility in Suzhou, China

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the company's global manufacturing footprint and establishes local production capabilities to meet increased customer demand in China and other Asia-Pacific markets.

From Thermo Fisher Scientific Inc. 16 Nov 2012

Paxvax PXVX0200 cholera vaccine demonstrates safety and immunogenicity in Phase 1 clinical trial

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner today announced results from a Phase 1 clinical trial of PaxVax's single-dose oral cholera vaccine candidate at the 2012 American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting in Atlanta.

15 Nov 2012

Men with wider variation in sperm length have fertility problems

Perhaps variety is the very spice of life, but as a matter of producing human life, it could be the bane of existence. That's the indication of a new study in the journal Human Reproduction that found men with wider variation in sperm length, particularly in the flagellum, had lower concentrations of sperm that could swim well. Those with more consistently made sperm seemed to have more capable ones.

14 Nov 2012

AspenBio Pharma provides clinical and business update for third quarter 2012

AspenBio Pharma, Inc., an in vitro diagnostic company, today provided a clinical and business update for the third quarter 2012. The Company reported it has started the hospital training phase of its pivotal U.S. clinical study and remains on track to initiate patient enrollment before the end of the year.

13 Nov 2012

Manufacturing News and Research

Further Reading

FDA grants final approval to Cobrek’s generic Luxiq foam NDA for treatment of scalp psoriasis

Gilead Sciences receives EC approval for Viread to treat HIV-1 infected children

Neusoft Medical receives FDA 510k clearance for NeuViz 64 multi-slice CT scanner

Philips Healthcare, UH to showcase latest medical technology at Cleveland Medical Mart

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

Patheon announces cash tender offer for all outstanding 8.625% Senior Secured Notes

Food hardness affects bolus size, swallowing

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

Mazzetti, AGR to develop technologies that can capture anesthetic gases in hospitals

Computer-based simulation modeling to determine ED HIV screening costs

Patheon to launch $30 million transferable rights offering

KemPharm announces successful Type B meeting with FDA for KP201

Certain occupations do increase risk of breast cancer

New nanoparticle halts relapsing remitting multiple sclerosis in mouse model

NIH-funded scientists develop new treatment to combat autoimmune disorders in mouse model

United States Pharmacopeial Convention to host Fifth Bioassay Workshop in Rockville

Thermo Fisher announces opening of new facility in Suzhou, China

Paxvax PXVX0200 cholera vaccine demonstrates safety and immunogenicity in Phase 1 clinical trial

Men with wider variation in sperm length have fertility problems

AspenBio Pharma provides clinical and business update for third quarter 2012

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy